Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.
The respected chemical supplier Alfa Chemistry now offers a complete range of isotope-labeled standards and reference materials. The launch of this product line targets the specific requirements of ...
Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback